101 related articles for article (PubMed ID: 20189046)
21. Management of anemia in patients with kidney disease in 2013 and beyond.
Wish JB
Nephrol News Issues; 2013 Jun; 27(7):Supp 1-3. PubMed ID: 23855140
[No Abstract] [Full Text] [Related]
22. The TREAT study answers a question, not the question.
Coyne DW
Am J Kidney Dis; 2008 Sep; 52(3):626-7; author reply 627-8. PubMed ID: 18725019
[No Abstract] [Full Text] [Related]
23. The etiology of anemia in heart failure. Preface.
Agarwal AK; Katz SD; Singh AK
Heart Fail Clin; 2010 Jul; 6(3):xvii-xviii. PubMed ID: 20630400
[No Abstract] [Full Text] [Related]
24. Use of erythropoietins in patients with renal transplants.
Treleaven DJ; Clase CM
BMJ; 2009 Oct; 339():b3825. PubMed ID: 19854838
[No Abstract] [Full Text] [Related]
25. A monocentric observational study of darbepoetin alfa in anemic hepatitis-C-virus transplant patients treated with ribavirin.
Kamar N; Guitard J; Ribes D; Esposito L; Rostaing L
Exp Clin Transplant; 2008 Dec; 6(4):271-5. PubMed ID: 19338488
[TBL] [Abstract][Full Text] [Related]
26. Quality of life in CKD patients treated with erythropoiesis-stimulating agents.
Parfrey PS; Wish T
Am J Kidney Dis; 2010 Mar; 55(3):423-5. PubMed ID: 20189050
[No Abstract] [Full Text] [Related]
27. Erythropoietin: high profile, high scrutiny.
Crawford J
J Clin Oncol; 2007 Mar; 25(9):1021-3. PubMed ID: 17312331
[No Abstract] [Full Text] [Related]
28. Are there implications from the Trial to Reduce Cardiovascular Events with Aranesp Therapy study for anemia management in dialysis patients?
Berns JS
Curr Opin Nephrol Hypertens; 2010 Nov; 19(6):567-72. PubMed ID: 20601876
[TBL] [Abstract][Full Text] [Related]
29. New limits advised for anemia drugs.
Mitka M
JAMA; 2007 Jun; 297(22):2464. PubMed ID: 17565074
[No Abstract] [Full Text] [Related]
30. [Anaemia correction in diabetic patients with chronic kidney disease without substitutive treatment: teachings from TREAT study].
de Francisco AL; Aljama P; Arias M; Fernández E; Górriz JL; Gómez JM; Castelao AM; Portolés J
Nefrologia; 2010; 30(1):15-20. PubMed ID: 20038964
[No Abstract] [Full Text] [Related]
31. [CERA: Continuous Erythropoietin Receptor Activator for anemia in CKD patients].
Cozzolino M
G Ital Nefrol; 2009; 26(1):8. PubMed ID: 19255955
[No Abstract] [Full Text] [Related]
32. [Renal anemia treatment and outcome of patients with chronic kidney disease].
Kuragano T; Nakanishi T
Nihon Jinzo Gakkai Shi; 2009; 51(7):852-6. PubMed ID: 19928557
[No Abstract] [Full Text] [Related]
33. Darbepoetin alfa and chronic kidney disease.
Locatelli F; Del Vecchio L; Casartelli D
N Engl J Med; 2010 Feb; 362(7):654-5; author reply 655. PubMed ID: 20187259
[No Abstract] [Full Text] [Related]
34. Comment: Epoetin alfa versus darbepoetin alfa for cancer patients with treatment-related anemia.
Yang MC
Ann Pharmacother; 2006 May; 40(5):998-9; author reply 999. PubMed ID: 16670351
[No Abstract] [Full Text] [Related]
35. Rebates for anti-anemia drugs draw response from FDA, CMS.
Sipkoff M
Manag Care; 2007 Jun; 16(6):17-8. PubMed ID: 17682732
[No Abstract] [Full Text] [Related]
36. Survey of attitude of physicians on updates in the management of anemia in chronic kidney disease patients.
Souqiyyeh MZ; Shaheen FA
Saudi J Kidney Dis Transpl; 2009 May; 20(3):410-6. PubMed ID: 19414943
[TBL] [Abstract][Full Text] [Related]
37. Myocardial disease, anemia, and erythrocyte-stimulating proteins in chronic kidney disease.
Foley RN
Rev Cardiovasc Med; 2005; 6 Suppl 3():S27-34. PubMed ID: 16340936
[TBL] [Abstract][Full Text] [Related]
38. Darbepoetin alfa and chronic kidney disease.
Wright RJ; Kanagasundaram NS; Quinton R
N Engl J Med; 2010 Feb; 362(7):653; author reply 655. PubMed ID: 20164489
[No Abstract] [Full Text] [Related]
39. Baseline characteristics in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT).
Pfeffer MA; Burdmann EA; Chen CY; Cooper ME; de Zeeuw D; Eckardt KU; Ivanovich P; Kewalramani R; Levey AS; Lewis EF; McGill J; McMurray JJ; Parfrey P; Parving HH; Remuzzi G; Singh AK; Solomon SD; Toto R; Uno H;
Am J Kidney Dis; 2009 Jul; 54(1):59-69. PubMed ID: 19501439
[TBL] [Abstract][Full Text] [Related]
40. Darbepoetin alfa and chronic kidney disease.
Hampl H; Kovesdy CP; Kalantar-Zadeh K
N Engl J Med; 2010 Feb; 362(7):654; author reply 655. PubMed ID: 20187260
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
